sefulness of using C-11 methionine PET in patient which suspected glioma
- Conditions
- glioma
- Registration Number
- JPRN-jRCTs012180017
- Lead Sponsor
- Yamaguchi Shigeru
- Brief Summary
C-11 methionine-PET will be useful as an additional test for MRI by the following reasons. 1) C-11 methionine-PET detects tumor cells in MRI negative sites with high PPV. 2) In cases which have C-11 methionine-PET test, the rate of without additive effect was low. 3)There was few false negative case.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 72
(1)The patients whose doctor plans a biopsy or tumor resection and whose tumor is suspected as primary glioma by board-certified diagnostic radiologists and board-certified neurosurgeons based on clinical manifestations, clinical courses, and MRI findings.
(2)The patients who or whose legal representative gave a written informed consent to this study.
(1)The patients with a history of serious allergic reaction to C-11 methionine or F-18 FDG.
(2)Pregnant women, breast-feeding women, or women who may be pregnant
(3)The patients who is participating in other trials
(4)The patients who underwent C-11 methionine PET within 90 days
(5)The patients whose overall status is not satisfactory for surgical treatment
(6) The patients who cannot undergo contrast-enhanced MRI
(7) The patients whom investigators judged to be inadequate as candidates
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.